BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
search help
Documents 1-3 out of 3 found
  Current Search:  apidra: 7, insulin: 31310, glulisine: 2, recombinant: 40084  
88%
PDF
PDF cover 0515.qxd
This weeks UK PDJ reports the expiry of the SPC awarded to Prodes SA for aceclofenac on 18th March, 2005.
Aventis applied for an SPC on EP885961, to cover Insulin Glulisine (Apidra), a fast- acting insulin analog with a more rapid onset of action and a shorter duration of action than regular human insulin.
Watson Pharmaceuticals, more known as a...

author: MSparrowhawk
Matching: apidra insulin glulisine Find similar documents More document info

88%
PDF
PDF cover 0515.qxd page 1


author: MSparrowhawk
Matching: apidra insulin glulisine Find similar documents More document info

60%
HTML
BIOPHARMA FDA Approvals
for use as a spreading agent to facilitate the dispersion and absorption of drugs, particularly local anesthetics, during ophthalmic surgery; for hypodermoclysis; and as an adjunct in subcutaneous urography for improving resorption of radiopaque agents Insulin glulisine, rDNA [Apidra; [LysB3, GluB29] insulin; insulin (human), 3B-l-lysine, 29B-l-glutamic acid-,...
Matching: apidra insulin recombinant Find similar documents More document info
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.